Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
Tags:
FDA, GLP-1 agonists, Ozempic, Wegovy, Novo Nordisk, drug shortages, Eli Lilly, Zepbound
On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study
Fierce Pharma
Tue, 10/15/24 - 10:15 am
Tags:
Eli Lilly, Crohn's Disease, Omvoh, clinical trials, JNJ, Stelara
FDA, facing pressure, to review position on Zepbound, Mounjaro shortage
BioPharma Dive
Mon, 10/14/24 - 11:17 pm
Tags:
Eli Lilly, drug shortages, Zebound, Mounjaro, FDA
Lilly picks UK for first European Gateway Lab as part of $364M investment plan
Fierce Biotech
Mon, 10/14/24 - 10:28 am
Tags:
Eli Lilly, Gateway Labs, incubators, Europe
FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Reuters
Sun, 10/13/24 - 11:33 am
Tags:
FDA, Eli Lilly, compounded drugs, drug shortages, obesity drugs, tirzepatide
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Tags:
Novo Nordisk, Eli Lilly, obesity, Zebound, Wegovy, CagriSema, Amgen, MariTide, oforglipron, Veru, enobosarm, nimacimab, Skye Bioscience
Lilly names Mount Sinai scientist as first chief AI officer
BioPharma Dive
Wed, 10/9/24 - 09:05 pm
Tags:
Eli Lilly, artificial intelligence
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases
BioSpace
Wed, 10/9/24 - 09:46 am
Tags:
Insitro, Eli Lilly, siRNA, MASH
Weight loss gold rush: Developers vie for next blockbuster treatment
Pharmaphorum
Tue, 10/8/24 - 09:45 am
Tags:
R&D, obesity, weight loss, Novo Nordisk, Eli Lilly, Roche, Boehringer Ingelheim
Lilly's weight-loss drug removed from FDA's shortage list
Reuters
Thu, 10/3/24 - 10:06 am
Tags:
Eli Lilly, FDA, drug shortages, Mounjaro
High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project
Fierce Pharma
Wed, 10/2/24 - 11:27 am
Tags:
Eli Lilly, JNJ, medicine foundry, drug manufacturing
Weight Loss From GLP-1 Drugs Not As Robust In Real-World Settings
Forbes
Wed, 10/2/24 - 11:20 am
Tags:
weight loss, obesity, GLP-1 agonist, Ozempic, Wegovy, Novo Nordisk, Zepbound, Mounjaro, Eli Lilly
Patients sue over alleged stomach paralysis linked to Ozempic, Mounjaro
Beckers Hospital Review
Tue, 10/1/24 - 10:45 am
Tags:
legal, Novo Nordisk, Eli Lilly, Ozempic, Mounjaro, gastroparesis
Radiopharma biotech Aktis sees Big Pharma backers return for $175M series B
Fierce Biotech
Mon, 09/30/24 - 09:40 am
Tags:
Eli Lilly, Aktis Oncology, funding, radiopharmaceuticals
Inside the GLP-1 'price war'
Beckers Hospital Review
Tue, 09/24/24 - 11:52 am
Tags:
GLP-1 agonists, obesity, weight loss, Eli Lilly, Novo Nordisk, Ozempic, Wegovy, Zepbound, Mounjaro, drug pricing
Eli Lilly's Alzheimer's drug approved in Japan
Reuters
Tue, 09/24/24 - 11:39 am
Tags:
Eli Lilly, Japan, donanemab, Alzheimer's disease
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
Tags:
migraines, BMJ, Pfizer, Nurtec, AbbVie, Ubrelvy, Eli Lilly, Reyvow
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Fierce Pharma
Tue, 09/17/24 - 11:08 pm
Tags:
Novartis, FDA, Eli Lilly, breast cancer, Kisqali
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Tags:
Eli Lilly, ESMO, lutetium zadavotide guraxetan, Astellas, Janssen, metastatic castration-resistant prostate cancer
FDA approves Eli Lilly's drug for eczema
Reuters
Mon, 09/16/24 - 10:16 pm
Tags:
Eli Lilly, FDA, eczema, Ebgylss

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.